314 related articles for article (PubMed ID: 25638740)
1. A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal.
Reynolds PM; Mueller SW; MacLaren R
Alcohol; 2015 Feb; 49(1):15-9. PubMed ID: 25638740
[TBL] [Abstract][Full Text] [Related]
2. Increased serum neurotrophin levels related to alcohol use disorder in a young population sample.
Lhullier AC; Moreira FP; da Silva RA; Marques MB; Bittencourt G; Pinheiro RT; Souza LD; Portela LV; Lara DR; Jansen K; Wiener CD; Oses JP
Alcohol Clin Exp Res; 2015 Jan; 39(1):30-3. PubMed ID: 25623403
[TBL] [Abstract][Full Text] [Related]
3. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal.
Heberlein A; Muschler M; Wilhelm J; Frieling H; Lenz B; Gröschl M; Kornhuber J; Bleich S; Hillemacher T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1060-4. PubMed ID: 20553781
[TBL] [Abstract][Full Text] [Related]
4. Serum brain-derived neurotrophic factor and nerve growth factor concentrations change after alcohol withdrawal: preliminary data of a case-control comparison.
Köhler S; Klimke S; Hellweg R; Lang UE
Eur Addict Res; 2013; 19(2):98-104. PubMed ID: 23128606
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic factors, clinical features and gender differences in depression.
de Azevedo Cardoso T; Mondin TC; Wiener CD; Marques MB; Fucolo Bde Á; Pinheiro RT; de Souza LD; da Silva RA; Jansen K; Oses JP
Neurochem Res; 2014 Aug; 39(8):1571-8. PubMed ID: 24899094
[TBL] [Abstract][Full Text] [Related]
6. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence.
Lee BC; Choi IG; Kim YK; Ham BJ; Yang BH; Roh S; Choi J; Lee JS; Oh DY; Chai YG
Alcohol; 2009 Jun; 43(4):265-9. PubMed ID: 19560628
[TBL] [Abstract][Full Text] [Related]
7. Serum nerve growth factor beta, brain- and glial-derived neurotrophic factor levels and psychopathology in unmedicated patients with schizophrenia.
Chu CS; Chu CL; Wu CC; Lu T
J Chin Med Assoc; 2018 Jun; 81(6):577-581. PubMed ID: 29366645
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
[TBL] [Abstract][Full Text] [Related]
10. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
11. Physical therapy intervention (PTI) increases plasma brain-derived neurotrophic factor (BDNF) levels in non-frail and pre-frail elderly women.
Coelho FM; Pereira DS; Lustosa LP; Silva JP; Dias JM; Dias RC; Queiroz BZ; Teixeira AL; Teixeira MM; Pereira LS
Arch Gerontol Geriatr; 2012; 54(3):415-20. PubMed ID: 21684022
[TBL] [Abstract][Full Text] [Related]
12. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats.
Morcuende S; Muñoz-Hernández R; Benítez-Temiño B; Pastor AM; de la Cruz RR
Neuroscience; 2013 Oct; 250():31-48. PubMed ID: 23827308
[TBL] [Abstract][Full Text] [Related]
14. Effects of cognitive-behavioral therapy on neurotrophic factors in patients with major depressive disorder.
da Silva SK; Wiener C; Ghisleni G; Oses JP; Jansen K; Molina ML; Silva R; Souza LD
Braz J Psychiatry; 2018; 40(4):361-366. PubMed ID: 29898192
[TBL] [Abstract][Full Text] [Related]
15. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
[TBL] [Abstract][Full Text] [Related]
16. Effects of dexmedetomidine on the release of glial cell line-derived neurotrophic factor from rat astrocyte cells.
Yan M; Dai H; Ding T; Dai A; Zhang F; Yu L; Chen G; Chen Z
Neurochem Int; 2011 Apr; 58(5):549-57. PubMed ID: 21241763
[TBL] [Abstract][Full Text] [Related]
17. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal.
Huang MC; Chen CH; Chen CH; Liu SC; Ho CJ; Shen WW; Leu SJ
Alcohol Alcohol; 2008; 43(3):241-5. PubMed ID: 18326550
[TBL] [Abstract][Full Text] [Related]
18. Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury.
Chiaretti A; Piastra M; Polidori G; Di Rocco C; Caresta E; Antonelli A; Amendola T; Aloe L
Intensive Care Med; 2003 Aug; 29(8):1329-38. PubMed ID: 12845427
[TBL] [Abstract][Full Text] [Related]
19. Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion.
Price TJ; Louria MD; Candelario-Soto D; Dussor GO; Jeske NA; Patwardhan AM; Diogenes A; Trott AA; Hargreaves KM; Flores CM
BMC Neurosci; 2005 Jan; 6():4. PubMed ID: 15667652
[TBL] [Abstract][Full Text] [Related]
20. Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity.
Pallavi P; Sagar R; Mehta M; Sharma S; Subramanium A; Shamshi F; Sengupta U; Qadri R; Pandey RM; Mukhopadhyay AK
J Affect Disord; 2013 Sep; 150(2):415-23. PubMed ID: 23769609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
